Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
—
Political receipts
—
Lobbying income
—
Lobbying expense
—
Federal awards
—
Relationships
54
| insider of | Ardelyx Inc | 99,578,729.61 | Dec 23, 2014 – Dec 15, 2021 |
| insider of | Inc. Robinhood Markets | 77,148,326.04 | Aug 2, 2021 – May 2, 2022 |
| insider of | Inc. Cloudflare | 76,532,031.2 | May 19, 2020 – Nov 11, 2020 |
| insider of | Appian Corp | 66,073,750.64 | May 31, 2017 – Feb 13, 2018 |
| insider of | Adaptimmune Therapeutics PLC | 54,104,645.34 | Mar 27, 2017 – Jan 24, 2020 |
| insider of | Cvent Inc | 46,318,358.47 | Aug 14, 2013 – Nov 25, 2014 |
| insider of | Trevi Therapeutics, Inc. | 32,538,535.68 | May 9, 2019 – Apr 17, 2025 |
| insider of | Inc. Aveo Pharmaceuticals | 24,666,875.46 | Mar 28, 2017 – Oct 19, 2022 |
| insider of | Peplin Inc | 24,540,596.664 | Mar 10, 2009 – Nov 11, 2009 |
| insider of | Epizyme, Inc. | 24,143,401.2 | Jun 5, 2013 – Jan 12, 2016 |
| insider of | Inc. Genocea Biosciences | 23,269,837.39 | Feb 14, 2019 – May 25, 2022 |
| insider of | Millennial Media Inc. | 21,474,257.28 | Apr 3, 2012 – Oct 29, 2012 |
| insider of | Monte Rosa Therapeutics, Inc. | 19,950,000 | Jun 28, 2021 – Jun 28, 2021 |
| insider of | Clovis Oncology, Inc. | 17,111,887 | Nov 21, 2011 – Jun 3, 2013 |
| insider of | Regulus Therapeutics Inc. | 16,670,039.64 | May 7, 2019 – Dec 4, 2020 |
| insider of | Mersana Therapeutics, Inc. | 15,205,139.2 | Jul 3, 2017 – Sep 14, 2020 |
| insider of | SpyGlass Pharma, Inc. | 15,000,000 | Feb 9, 2026 – Feb 9, 2026 |
| insider of | Viracta Therapeutics, Inc. | 13,506,839.68 | Oct 30, 2009 – Aug 29, 2014 |
| insider of | Innerworkings Inc | 12,618,561.05 | Oct 10, 2007 – Mar 28, 2012 |
| insider of | Nkarta, Inc. | 11,999,988 | Jul 14, 2020 – Jul 14, 2020 |
| insider of | Metacrine, Inc. | 10,493,898.52 | Sep 18, 2020 – Dec 22, 2021 |
| insider of | Omthera Pharmaceuticals, Inc. | 10,068,882.5 | Apr 11, 2013 – Jul 18, 2013 |
| insider of | Marker Therapeutics, Inc. | 9,999,998.75 | Mar 16, 2021 – Mar 16, 2021 |
| insider of | Tracon Pharmaceuticals, Inc. | 9,999,998.75 | Feb 4, 2015 – Nov 29, 2016 |
| insider of | Akouos, Inc. | 9,999,995 | Jun 30, 2020 – Nov 30, 2022 |
| insider of | Inc. Synlogic | 9,997,494 | Oct 5, 2015 – Jan 26, 2018 |
| insider of | Rhythm Pharmaceuticals, Inc. | 9,350,000 | Oct 10, 2017 – Oct 10, 2017 |
| insider of | MBX Biosciences, Inc. | 8,000,000 | Sep 16, 2024 – Sep 16, 2024 |
| insider of | Inc. Mirum Pharmaceuticals | 6,750,000 | Jul 22, 2019 – Jun 13, 2023 |
| insider of | Achaogen, Inc. | 6,750,000 | Dec 19, 2016 – Dec 19, 2016 |
| insider of | Liquidia Technologies Inc | 6,000,005 | Jul 30, 2018 – Jul 30, 2018 |
| insider of | Korro Bio, Inc. | 5,999,991.95 | Apr 22, 2024 – Mar 10, 2026 |
| insider of | Cascadian Therapeutics, Inc. | 5,999,400 | Feb 20, 2018 – Mar 9, 2018 |
| insider of | Eargo, Inc. | 5,599,998 | Oct 20, 2020 – May 24, 2021 |
| insider of | Roka BioScience, Inc. | 4,599,996 | Jul 22, 2014 – Sep 21, 2016 |
| insider of | Ra Pharmaceuticals, Inc. | 4,411,307.06 | Oct 31, 2016 – Oct 31, 2016 |
| insider of | Inozyme Pharma, Inc. | 4,000,000 | Jul 25, 2020 – Jul 28, 2020 |
| insider of | Interleukin Genetics Inc | 3,998,968.9 | Dec 23, 2014 – Jul 29, 2016 |
| insider of | Inc. Supernus Pharmaceuticals | 3,711,507.27 | Jun 15, 2015 – Nov 11, 2015 |
| insider of | Loxo Oncology, Inc. | 2,999,997 | Aug 6, 2014 – Aug 6, 2014 |
| insider of | Surface Oncology, Inc. | 1,999,995 | Apr 23, 2018 – Apr 23, 2018 |
| insider of | Dermira, Inc. | 1,105,792 | Oct 8, 2014 – Oct 8, 2014 |
| insider of | Audience Inc | 1,084,556.45 | May 15, 2012 – Dec 3, 2013 |
| insider of | Savara Inc. | 999,999 | Jul 17, 2023 – Jul 17, 2023 |
| insider of | Oruka Therapeutics, Inc. | 730,104.5 | Feb 26, 2018 – Feb 26, 2018 |